Dudediligence.

OnKure Therapeutics, Inc

OKURNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Reported ·

$4,477

6 sales · 0 buys

Oct 2025 to Jun 2026

None of the 6 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2025-12-22: Saccomano Nicholas A, sold2025-12-22: Leverone Jason A., sold2026-03-23: Saccomano Nicholas A, sold2026-03-23: Leverone Jason A., sold2026-06-22: Saccomano Nicholas A, sold2026-06-22: Leverone Jason A., sold
under a no plan named▼ salesize is dollars

Form 4 filings, newest first

2026-06-22Saccomano Nicholas A$378
▼ sold86 shno plan namedForm 4 ↗
2026-06-22Leverone Jason A.$1,333
▼ sold303 shno plan namedForm 4 ↗
2026-03-23Saccomano Nicholas A$358
▼ sold86 shno plan namedForm 4 ↗
2026-03-23Leverone Jason A.$1,252
▼ sold301 shno plan namedForm 4 ↗
2025-12-22Saccomano Nicholas A$258
▼ sold87 shno plan namedForm 4 ↗
2025-12-22Leverone Jason A.$897
▼ sold302 shno plan namedForm 4 ↗